Literature DB >> 11294892

Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo.

J A Aguirre-Ghiso1, D Liu, A Mignatti, K Kovalski, L Ossowski.   

Abstract

We discovered that a shift between the state of tumorigenicity and dormancy in human carcinoma (HEp3) is attained through regulation of the balance between two classical mitogen-activated protein kinase (MAPK)-signaling pathways, the mitogenic extracellular regulated kinase (ERK) and the apoptotic/growth suppressive stress-activated protein kinase 2 (p38(MAPK)), and that urokinase plasminogen activator receptor (uPAR) is an important regulator of these events. This is a novel function for uPAR whereby, when expressed at high level, it enters into frequent, activating interactions with the alpha5beta1-integrin, which facilitates the formation of insoluble fibronectin (FN) fibrils. Activation of alpha5beta1-integrin by uPAR generates persistently high level of active ERK necessary for tumor growth in vivo. Our results show that ERK activation is generated through a convergence of two pathways: a positive signal through uPAR-activated alpha5beta1, which activates ERK, and a signal generated by the presence of FN fibrils that suppresses p38 activity. When fibrils are removed or their assembly is blocked, p38 activity increases. Low uPAR derivatives of HEp3 cells, which are growth arrested (dormant) in vivo, have a high p38/ERK activity ratio, but in spite of a similar level of alpha5beta1-integrin, they do not assemble FN fibrils. However, when p38 activity is inhibited by pharmacological (SB203580) or genetic (dominant negative-p38) approaches, their ERK becomes activated, uPAR is overexpressed, alpha5beta1-integrins are activated, and dormancy is interrupted. Restoration of these properties in dormant cells can be mimicked by a direct re-expression of uPAR through transfection with a uPAR-coding plasmid. We conclude that overexpression of uPAR and its interaction with the integrin are responsible for generating two feedback loops; one increases the ERK activity that feeds back by increasing the expression of uPAR. The second loop, through the presence of FN fibrils, suppresses p38 activity, further increasing ERK activity. Together these results indicate that uPAR and its interaction with the integrin should be considered important targets for induction of tumor dormancy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11294892      PMCID: PMC32272          DOI: 10.1091/mbc.12.4.863

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  40 in total

1.  Changes in integrin receptors on oncogenically transformed cells.

Authors:  L C Plantefaber; R O Hynes
Journal:  Cell       Date:  1989-01-27       Impact factor: 41.582

2.  Transcriptional repression of fibronectin gene expression in v-src transformation.

Authors:  H Gu; N Oliver
Journal:  Exp Cell Res       Date:  1995-04       Impact factor: 3.905

3.  Activation of the protein kinase p38 in the spindle assembly checkpoint and mitotic arrest.

Authors:  K Takenaka; T Moriguchi; E Nishida
Journal:  Science       Date:  1998-04-24       Impact factor: 47.728

4.  Elevated levels of the alpha 5 beta 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells.

Authors:  F G Giancotti; E Ruoslahti
Journal:  Cell       Date:  1990-03-09       Impact factor: 41.582

5.  Bidirectional regulation of p38 kinase and c-Jun N-terminal protein kinase by insulin-like growth factor-I.

Authors:  H L Cheng; E L Feldman
Journal:  J Biol Chem       Date:  1998-06-05       Impact factor: 5.157

6.  A test of the role of alpha5 integrin/fibronectin interactions in tumorigenesis.

Authors:  D Taverna; M Ullman-Culleré; H Rayburn; R T Bronson; R O Hynes
Journal:  Cancer Res       Date:  1998-02-15       Impact factor: 12.701

7.  Changes in malignant phenotype of a human carcinoma conditioned by growth environment.

Authors:  L Ossowski; E Reich
Journal:  Cell       Date:  1983-06       Impact factor: 41.582

8.  A novel mechanism of Ha-ras oncogene action: regulation of fibronectin mRNA levels by a nuclear posttranscriptional event.

Authors:  L A Chandler; C P Ehretsmann; S Bourgeois
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

9.  Sequestration of GPI-anchored proteins in caveolae triggered by cross-linking.

Authors:  S Mayor; K G Rothberg; F R Maxfield
Journal:  Science       Date:  1994-06-24       Impact factor: 47.728

10.  Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression.

Authors:  Z Werb; P M Tremble; O Behrendtsen; E Crowley; C H Damsky
Journal:  J Cell Biol       Date:  1989-08       Impact factor: 10.539

View more
  147 in total

Review 1.  Staying alive: metabolic adaptations to quiescence.

Authors:  James R Valcourt; Johanna M S Lemons; Erin M Haley; Mina Kojima; Olukunle O Demuren; Hilary A Coller
Journal:  Cell Cycle       Date:  2012-05-01       Impact factor: 4.534

2.  Functional convergence of signalling by GPI-anchored and anchorless forms of a salamander protein implicated in limb regeneration.

Authors:  Robert A Blassberg; Acely Garza-Garcia; Azara Janmohamed; Phillip B Gates; Jeremy P Brockes
Journal:  J Cell Sci       Date:  2010-11-30       Impact factor: 5.285

3.  Design, synthesis, biochemical studies, cellular characterization, and structure-based computational studies of small molecules targeting the urokinase receptor.

Authors:  Fang Wang; W Eric Knabe; Liwei Li; Inha Jo; Timmy Mani; Hartmut Roehm; Kyungsoo Oh; Jing Li; May Khanna; Samy O Meroueh
Journal:  Bioorg Med Chem       Date:  2012-06-12       Impact factor: 3.641

4.  MAPKs' status at early stages of renal carcinogenesis and tumors induced by ferric nitrilotriacetate.

Authors:  Francisco A Aguilar-Alonso; José D Solano; Chabetty Y Vargas-Olvera; Ignacio Pacheco-Bernal; Telma O Pariente-Pérez; María Elena Ibarra-Rubio
Journal:  Mol Cell Biochem       Date:  2015-02-28       Impact factor: 3.396

5.  TBK1 regulates prostate cancer dormancy through mTOR inhibition.

Authors:  Jin Koo Kim; Younghun Jung; Jingcheng Wang; Jeena Joseph; Anjali Mishra; Elliott E Hill; Paul H Krebsbach; Kenneth J Pienta; Yusuke Shiozawa; Russell S Taichman
Journal:  Neoplasia       Date:  2013-09       Impact factor: 5.715

6.  Temporal and spatial cooperation of Snail1 and Twist1 during epithelial-mesenchymal transition predicts for human breast cancer recurrence.

Authors:  David D Tran; Callie Ann S Corsa; Hirak Biswas; Rebecca L Aft; Gregory D Longmore
Journal:  Mol Cancer Res       Date:  2011-10-17       Impact factor: 5.852

Review 7.  Tumor cell dormancy induced by p38SAPK and ER-stress signaling: an adaptive advantage for metastatic cells?

Authors:  Aparna C Ranganathan; Alejandro P Adam; Lin Zhang; Julio A Aguirre-Ghiso
Journal:  Cancer Biol Ther       Date:  2006-07-01       Impact factor: 4.742

8.  Functional coupling of p38-induced up-regulation of BiP and activation of RNA-dependent protein kinase-like endoplasmic reticulum kinase to drug resistance of dormant carcinoma cells.

Authors:  Aparna C Ranganathan; Lin Zhang; Alejandro P Adam; Julio A Aguirre-Ghiso
Journal:  Cancer Res       Date:  2006-02-01       Impact factor: 12.701

9.  A dual role for caveolin-1 in the regulation of fibronectin matrix assembly by uPAR.

Authors:  Elizabeth Monaghan-Benson; Cynthia Corley Mastick; Paula J McKeown-Longo
Journal:  J Cell Sci       Date:  2008-10-28       Impact factor: 5.285

10.  Tumor dormancy due to failure of angiogenesis: role of the microenvironment.

Authors:  George N Naumov; Judah Folkman; Oddbjorn Straume
Journal:  Clin Exp Metastasis       Date:  2008-06-18       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.